Tags

Type your tag names separated by a space and hit enter

[Hypergonadotropic amenorrhea (WHO III) as osteoporosis risk].
Geburtshilfe Frauenheilkd. 1990 Dec; 50(12):974-6.GF

Abstract

In 21 patients, suffering from amenorrhoeic hypergonadotropic ovarian insufficiency (age 27 +/- 3 years [FSH: 43 +/- 10, LH: 40 +/- 8]), the bone density was measured by single-photon densitometry (SPA), before starting a hormonal replacement therapy with oestrogen/progesterone. Every 5 months, the trend in bone density change was measured in all cases. The bone density before hormonal treatment was lower in the WHO III-group (1.36 +/- 0.21 g/cm; 1.09 +/- 0.26 g/cm2) than in the age-matched group (1.57 +/- 0.21 g/cm; 1.28 +/- 0.31 g/cm2). Bone density increased after hormonal therapy (p less than 0.05). These results point to the necessity of hormonal replacement therapy in cases of WHO III.

Authors+Show Affiliations

I. Univ.-Frauenklinik Wien.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

English Abstract
Journal Article

Language

ger

PubMed ID

2128289

Citation

Metka, M, et al. "[Hypergonadotropic Amenorrhea (WHO III) as Osteoporosis Risk]." Geburtshilfe Und Frauenheilkunde, vol. 50, no. 12, 1990, pp. 974-6.
Metka M, Heytmanek G, Enzelsberger H, et al. [Hypergonadotropic amenorrhea (WHO III) as osteoporosis risk]. Geburtshilfe Frauenheilkd. 1990;50(12):974-6.
Metka, M., Heytmanek, G., Enzelsberger, H., Huber, J., Kurz, C., & Spona, J. (1990). [Hypergonadotropic amenorrhea (WHO III) as osteoporosis risk]. Geburtshilfe Und Frauenheilkunde, 50(12), 974-6.
Metka M, et al. [Hypergonadotropic Amenorrhea (WHO III) as Osteoporosis Risk]. Geburtshilfe Frauenheilkd. 1990;50(12):974-6. PubMed PMID: 2128289.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Hypergonadotropic amenorrhea (WHO III) as osteoporosis risk]. AU - Metka,M, AU - Heytmanek,G, AU - Enzelsberger,H, AU - Huber,J, AU - Kurz,C, AU - Spona,J, PY - 1990/12/1/pubmed PY - 1990/12/1/medline PY - 1990/12/1/entrez SP - 974 EP - 6 JF - Geburtshilfe und Frauenheilkunde JO - Geburtshilfe Frauenheilkd VL - 50 IS - 12 N2 - In 21 patients, suffering from amenorrhoeic hypergonadotropic ovarian insufficiency (age 27 +/- 3 years [FSH: 43 +/- 10, LH: 40 +/- 8]), the bone density was measured by single-photon densitometry (SPA), before starting a hormonal replacement therapy with oestrogen/progesterone. Every 5 months, the trend in bone density change was measured in all cases. The bone density before hormonal treatment was lower in the WHO III-group (1.36 +/- 0.21 g/cm; 1.09 +/- 0.26 g/cm2) than in the age-matched group (1.57 +/- 0.21 g/cm; 1.28 +/- 0.31 g/cm2). Bone density increased after hormonal therapy (p less than 0.05). These results point to the necessity of hormonal replacement therapy in cases of WHO III. SN - 0016-5751 UR - https://www.unboundmedicine.com/medline/citation/2128289/[Hypergonadotropic_amenorrhea__WHO_III__as_osteoporosis_risk]_ L2 - https://www.thieme-connect.com/DOI/DOI?10.1055/s-2008-1026402 DB - PRIME DP - Unbound Medicine ER -